TY - JOUR
T1 - Ammonium chloride exposure inhibits cytokine-mediated eosinophil survival
AU - Ide, Mikako
AU - Weiler, Deborah
AU - Kita, Hirohito
AU - Gleich, Gerald J.
PY - 1994/2/10
Y1 - 1994/2/10
N2 - To study human eosinophils, their efficient purification from peripheral blood is crucial. Although a number of purification procedures, including discontinous Percoll and metrizamide density gradient centrifugation, have been used, it has been difficult to isolate eosinophils from normal donors with consistently high yields and purities. Recently, a new isolation technique called magnetic cell separation system (MACS) was reported. To evaluate this procedure, we isolated eosinophils from human peripheral blood using either MACS or the standard discontinuous Percoll density methods, and compared cellular viability, morphology, and response to degranulation stimuli. MACS gave a higher yield of eosinophils than Percoll density centrifugation; for example, 6.6 ± 1.1 × 106 eosinophils were isolated from 20 ml of blood by MACS compared to 6.4 ± 2.4 × 106 from 120 ml by Percoll density gradient. Further, the purity of eosinophils isolated by MACS was 97.1 ± 0.5% (X ± SEM) compared to 77.8 ± 2.9% with Percoll. As part of the MACS protocol, erythrocytes are lysed with either 155 mM ammonium chloride or hypotonic lysis. With 155 mM ammonium chloride treatment, the eosinophils showed a striking reduction in cytokine mediated survival due to interleukin (IL)-3, IL-5 and granulocyte-macrophage colony-stimulating factor (GM-CSF), marked morphologic abnormalities and a reduced degranulation response. With hypotonic lysis, no differences were observed in survival and morphology between eosinophils purified by MACS and Percoll methods; the degranulation responses to stimuli were essentially the same between the two methods. Taken together, these observations suggest that the exposure of eosinophils to 155 mM ammonium chloride results in cellular damage. Therefore, MACS with hypotonic lysis is a useful technique to isolate eosinophils for biological study.
AB - To study human eosinophils, their efficient purification from peripheral blood is crucial. Although a number of purification procedures, including discontinous Percoll and metrizamide density gradient centrifugation, have been used, it has been difficult to isolate eosinophils from normal donors with consistently high yields and purities. Recently, a new isolation technique called magnetic cell separation system (MACS) was reported. To evaluate this procedure, we isolated eosinophils from human peripheral blood using either MACS or the standard discontinuous Percoll density methods, and compared cellular viability, morphology, and response to degranulation stimuli. MACS gave a higher yield of eosinophils than Percoll density centrifugation; for example, 6.6 ± 1.1 × 106 eosinophils were isolated from 20 ml of blood by MACS compared to 6.4 ± 2.4 × 106 from 120 ml by Percoll density gradient. Further, the purity of eosinophils isolated by MACS was 97.1 ± 0.5% (X ± SEM) compared to 77.8 ± 2.9% with Percoll. As part of the MACS protocol, erythrocytes are lysed with either 155 mM ammonium chloride or hypotonic lysis. With 155 mM ammonium chloride treatment, the eosinophils showed a striking reduction in cytokine mediated survival due to interleukin (IL)-3, IL-5 and granulocyte-macrophage colony-stimulating factor (GM-CSF), marked morphologic abnormalities and a reduced degranulation response. With hypotonic lysis, no differences were observed in survival and morphology between eosinophils purified by MACS and Percoll methods; the degranulation responses to stimuli were essentially the same between the two methods. Taken together, these observations suggest that the exposure of eosinophils to 155 mM ammonium chloride results in cellular damage. Therefore, MACS with hypotonic lysis is a useful technique to isolate eosinophils for biological study.
KW - CD16
KW - Eosinophil
KW - Magnetic cell separation
KW - Purification
UR - http://www.scopus.com/inward/record.url?scp=0028269393&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028269393&partnerID=8YFLogxK
U2 - 10.1016/0022-1759(94)90054-X
DO - 10.1016/0022-1759(94)90054-X
M3 - Article
C2 - 8308293
AN - SCOPUS:0028269393
SN - 0022-1759
VL - 168
SP - 187
EP - 196
JO - Journal of Immunological Methods
JF - Journal of Immunological Methods
IS - 2
ER -